A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Aug 2018
At a glance
- Drugs Trastuzumab emtansine (Primary) ; Paclitaxel; Trastuzumab
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ATEMPT
- 31 Aug 2018 Biomarkers information updated
- 20 Aug 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Jan 2020.
- 30 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.